Malaria Host-Pathogen Interaction Center (MaHPIC)
The MaHPIC combines Emory investigators’ interdisciplinary experience in malaria research, metabolomics, lipidomics and human and non-human primate immunology and pathogenesis with UGA’s expertise in pathogen bioinformatics and large database systems, and Georgia Tech’s experience in mathematical modeling and systems biology. The CDC has provided support in proteomics and malaria research, including nonhuman primate and vector/mosquito infections. NIAID Grant HHSN272201200031C
||National Institute of Allergy and Infectious Diseases
||Mary Galinski (PI), Emory University
Alberto Moreno (Co-PI), Emory University
Jessica Kissinger (Co-PI), University of Georgia (Co-PI)
Co-Investigators from the BRG
Yi Heng Yan, Elizabeth Trippe, Zerotti Woods, Jessica Brady, Juan B. Gutierrez
||University of Georgia
Georgia Institute of Technology
Eight experimental and analytical research teams comprise the core infrastructure of the MaHPIC: Malaria, Immune Profiling, Functional Genomics, Proteomics, Metabolomics, Lipidomics, Informatics Core, Mathematical Modeling and Computational Analysis.
||$1.8M (UGA) of $19.5M (Project Total)
||Emory news center: NIH awards Georgia malaria research consortium up to $19.4 million contract
Atlanta Business Chronicle: Emory, GT, UGA partnership gets $19.5M for malaria
UGA TODAY: UGA partners with Emory, Georgia Tech and CDC Foundation on malaria research center
NPR (WABE90.1 Where ATL meets NPR): 19.4 Million Dollar Grant Forms Georgia Malaria Research Team
TheRed&Black: University, state continues history of malaria research
Vaccine News (VN daily): Researchers to open new malaria center in Georgia
Downtown.11alive.com (NBS): UGA, Ga. Tech, Emory team up for malaria research
The Augusta Chronicle: Malaria researchers in Ga. get federal contract
MaHPIC involves the multidisciplinary study of malaria infections, immunity and pathogenesis of P. falciparum, P. vivax and P. knowlesi in the context of host-pathogen interactions, in humans and nonhuman primates, using a systems biology approach. Three nonhuman primate malaria species will be studied: P. coatneyi to model P. falciparum, P. cynomolgi to model P. vivax, and P. knowlesi, a monkey malaria species that has been causing illness and cases of death in humans in Southeast Asia.
The Mathematical Modeling and Computational Analysis Team mines information from the rich biological datasets coming from MaHPIC’s Experimental groups and integrates this information, together with scientific knowledge from the literature, into static and dynamic mathematical, graphical, and computational models. These models are expected to aid our understanding of the disease, lead to novel, testable hypotheses, and ultimately assist in the development of new treatment strategies.
The team uses statistical and machine learning techniques to build correlative models that identify patterns within the data, as well as correlations to relevant phenotypes such as disease severity. Informed by these patterns, the team establishes static models that elucidate the steady-state interactions between components at different biological levels of organization, from genomes, proteomes, and different metabolic pathway systems, to cell populations in the hematopoietic and immune systems or in malaria affected tissues and organs, and finally to the drivers governing the interplay between hosts and parasites.
Based on insights gained with these efforts, develop dynamic models are developed that, in addition to static interactions, account for detailed regulatory features, multi-level control mechanisms, and changes in interaction patterns over time and throughout the progression of the disease. Models are developed for each host-pathogen combination, in order to enable an assessment of the similarities and differences between model systems and to explain in finer detail the characteristics of human infections where such detailed data are not available. The models have the potential of providing unprecedented insights into the systemic and dynamic aspects of malaria, as well as other infectious diseases.